Navigation Links
Attention Deficit Hyperactivity Disorder Market (ADHD) Analysis & 2018 Forecasts in New Research Report at RnRMarketResearch.com
Date:6/6/2013

Dallas, Texas (PRWEB) June 06, 2013

The impending publication of the fifth edition of the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM-V) may affect diagnosis rates of conditions such as Attention-Deficit/Hyperactivity Disorder (ADHD), both in the US and worldwide.

European countries are increasingly adopting the US diagnostic criteria (DSM-IV), resulting in more and more diagnoses of ADHD. This may eventually result in a rise in ADHD diagnoses even further afield.

Although Europe trails behind the US in terms of market revenue, ADHD therapeutics markets are expected to show strong growth, with Spain predicted to witness a Compound Annual Growth Rate (CAGR) of 8% over 2012-2018, beating the US CAGR of 6% during the same future period. European markets have not yet neared the saturation point that ADHD therapeutics are facing in the US, and there is an optimistic view for ambitious growth in this region. The ADHD therapeutics market across France, Germany, Italy, Spain and the UK is predicted to reach approximately $182m in 2018.

Get a copy of this report @ http://www.rnrmarketresearch.com/adhd-therapeutics-market-to-2018-market-report.html

This report “ADHD Therapeutics Market to 2018 – New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment” provides insights into the up-and-coming trends of the ADHD market in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan. The report includes market forecasts to 2019, detailed pipeline analysis, in-depth profiling of the major products and details of recent industry deals.

Scope:
Current and future treatment and diagnosis trends for ADHD & market forecasts for ADHD across seven major markets.

Analysis of the developmental pipelines for ADHD and information on recent industry deals.

Reasons to Buy:
Understand how the ADHD market has developed and is continuing to develop within the featured markets.

Predict which products are likely to be most successful in the future and gain an understanding of the possible market available for specific products.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99800

Browse more reports on Therapeutics Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics

About Us:
RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/2018-ADHD-therapeutics/market-analysis-report/prweb10807757.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. You Survived Cancer: Now Pay Attention to Your Overall Health
2. Blood Clot Risk for Outpatients Needs More Attention: Study
3. Excessive sleepiness may be cause of learning, attention and school problems
4. Study finds drug warning labels need overhaul to better capture attention, convey information
5. Brain development is delayed in attention-deficit/hyperactivity disorder
6. Preschool children who can pay attention more likely to finish college
7. Pay Attention in Preschool, Graduate From College: Study
8. Lights off? International experts call attention to dangers of exposure to light at night
9. Attention, parents: UC research reveals a secret about your medicine cabinet
10. Study suggests increased diagnosis rate of attention-deficit/hyperactivity disorder at health plan
11. Yale researchers spot attention deficits in babies who later develop autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
Breaking Medicine Technology: